In the TCGA and CGGA cohorts, WHO grade III gliomas showed higher levels of SERPINE1 mRNA than WHO grade II gliomas (p<0.001, respectively) (Figures 4A, C). The gene discussed is SERPINE1; the disease is central nervous system cancer.